0001600132-17-000114.txt : 20171011 0001600132-17-000114.hdr.sgml : 20171011 20171011102504 ACCESSION NUMBER: 0001600132-17-000114 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171011 DATE AS OF CHANGE: 20171011 EFFECTIVENESS DATE: 20171011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296368 FILM NUMBER: 171131969 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 D 1 primary_doc.xml X0708 D LIVE 0001600132 Bellerophon Therapeutics, Inc. 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ NEW JERSEY 07059 908-574-4770 DELAWARE Bellerophon Therapeutics LLC Corporation true 2013 Fabian Tenenbaum c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Director Jonathan M. Peacock c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Naseem P. Amin c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Scott P. Bruder c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Mary Ann Cloyd c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Jens Luehring c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Andre V. Moura c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Daniel Tasse c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Adam B. Weinstein c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Director Peter Fernandes c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Deborah A. Quinn c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Martin Dekker c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Amy Edmonds c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Parag Shah c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Megan Schoeps c/o Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ NEW JERSEY 07059 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-09-29 false true true true false 0 Theodore Wang 2786005 Angel Pond Capital LLC 287761 950 Third Avenue, 25th Floor New York NY NEW YORK 10022 CA CALIFORNIA NJ NEW JERSEY NY NEW YORK false 23437050 23437050 0 false 11 650000 0 0 false Bellerophon Therapeutics, Inc. /s/ Fabian Tenenbaum Fabian Tenenbaum Chief Executive Officer 2017-10-09